Duke Cancer Institute: New, Non-Hormonal Target Identified for Advanced Prostate Cancer
December 04, 2019
December 04, 2019
DURHAM, North Carolina, Dec. 4 -- Duke Cancer Institute issued the following news release:
* * *
- Drug tested in lab studies halts cancer cells that are impervious to hormone therapy
* * *
Hormone therapies for prostate cancer have greatly prolonged the lives of patients, but the drugs eventually become ineffective and the disease grows lethal.
Resistance occurs because a small percentage of prostate cancer cells are completely i . . .
* * *
- Drug tested in lab studies halts cancer cells that are impervious to hormone therapy
* * *
Hormone therapies for prostate cancer have greatly prolonged the lives of patients, but the drugs eventually become ineffective and the disease grows lethal.
Resistance occurs because a small percentage of prostate cancer cells are completely i . . .